| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating revenues: | ||||||||
License revenues | ||||||||
- | - | - | - | - | - | 500 | - | - |
Operating expenses: | ||||||||
Research and development | ||||||||
1,381 | 1,802 | 1,617 | 1,874 | 2,607 | 1,451 | 1,210 | 1,070 | 791 |
General and administrative | ||||||||
1,023 | 968 | 1,044 | 867 | 814 | 667 | 777 | 780 | 515 |
Total operating expenses | ||||||||
- | - | - | - | - | - | - | - | 1,306 |
Operating loss | ||||||||
-2,404 | -2,770 | -2,661 | -2,741 | -3,421 | -2,118 | -1,487 | -1,850 | -1,306 |
Other (income) expense: | ||||||||
Governmental assistance - research incentives | ||||||||
115 | 193 | 263 | 226 | 174 | 169 | 196 | 118 | 731 |
Other (income) expense, net | ||||||||
-127 | 99 | -38 | 54 | 4 | -7 | -39 | 13 | -35 |
Change in fair value of warrant liability | ||||||||
- | - | - | - | - | 0 | 0 | 0 | 39 |
Total other (income) expense | ||||||||
12 | 648 | 225 | 280 | -178 | 162 | 157 | 131 | 657 |
Loss before income tax expense | ||||||||
-2,416 | -2,478 | -2,436 | -2,461 | -3,243 | -1,956 | -1,330 | -1,719 | -649 |
Income tax expense | ||||||||
9 | 2 | 12 | 8 | 9 | 6 | 57 | 16 | 1 |
Net loss | ||||||||
-2,425 | -2,480 | -2,448 | -2,469 | -3,252 | -1,962 | -1,387 | -1,735 | -650 |
Other comprehensive income | ||||||||
Unrealized gain on marketable securities | ||||||||
40 | -4 | -5 | 8 | 3 | - | - | - | - |
Net loss and comprehensive loss | ||||||||
-2,385 | -2,484 | -2,453 | -2,461 | -3,249 | -1,962 | -1,387 | -1,735 | -650 |
Basic and diluted net loss per share (in dollars per share) | ||||||||
-0.19 | -0.21 | -0.20 | -0.21 | -0.27 | -0.24 | -0.18 | -0.22 | -0.10 |
Weighted average shares outstanding – basic and diluted (in shares) | ||||||||
13,107 | 12,007 | 12,006 | 11,979 | 11,956 | 8,769 | 7,836 | 7,821 | 6,546 |